Ranitidine Hydrochloride

Ranitidine Hydrochloride (CAS 66357-59-3), withdrawn in many markets because of NDMA. Supplied by Zyntex only for documented uses such as analytical reference standards and markets where it remains authorized.

SKU: 22071-15-4 Category: Tag:
Description
Ranitidine Hydrochloride (CAS 66357-59-3) is an H2-receptor antagonist whose medicines were withdrawn in many markets after 2019 because of NDMA impurity concerns. Zyntex supplies Ranitidine Hydrochloride only for authorized uses such as reference standards and markets where it remains permitted, with full documentation for every lot.

Ranitidine Hydrochloride Product Overview

Ranitidine hydrochloride (C13H22N4O3S·HCl) is a white to pale yellow crystalline powder that dissolves easily in water. For decades it was one of the most widely used acid-reducing medicines.

In 2019 and 2020, regulators found that ranitidine can form N-nitrosodimethylamine (NDMA), a probable human carcinogen, during storage. As a result, the US FDA requested withdrawal of all ranitidine products, and the EU suspended them, while many other countries followed. Most producers have since switched to Famotidine or proton pump inhibitors such as Omeprazole.

Notably, today, demand comes mainly from analytical laboratories that need reference material for NDMA testing, and from licensed companies in markets where ranitidine remains authorized. Zyntex therefore supplies it only for such documented, permitted uses.

Key Applications of Ranitidine Hydrochloride

Typical uses include, for example:

🔬 Reference Standards

Material for NDMA as well as impurity testing.

🧪 Analytical Methods

Reference for method development.

💊 Authorized Markets

API where still permitted.

📋 Regulated Supply

Supply only with documented use.

Ranitidine Hydrochloride Technical Specifications

ParameterStandard Value
Product NameRanitidine Hydrochloride
CAS Number66357-59-3
Molecular FormulaC13H22N4O3S · HCl
Assay / Purity97.0% – 103.0% (Dried Basis)
Regulatory StatusWithdrawn or suspended in many markets (NDMA)
DocumentsCoA, SDS and end-use declaration

⚠️ Safety & Handling: Pharmacologically active substance; may cause allergic reactions. Avoid inhalation of dust and contact, and also wear gloves and eye protection. Store in tightly closed containers in a cool, dry place, because heat can increase NDMA formation. Always consult the Safety Data Sheet (SDS), because it contains the full classification and handling instructions.

Frequently Asked Questions

Why were ranitidine medicines withdrawn?

Because regulators found that ranitidine can form the impurity NDMA during storage, many markets withdrew or suspended ranitidine products.

For which uses do you supply ranitidine?

Mainly as reference material for analytical laboratories, as well as for licensed companies in markets where it remains authorized.

How can I get a price and documents?

Prices depend on quantity, packaging and destination, so please contact us with your required volume. We then send a quotation together with the CoA and SDS.